4//SEC Filing
Feder Julie B 4
Accession 0000950170-23-057643
CIK 0001501796other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 6:24 PM ET
Size
5.3 KB
Accession
0000950170-23-057643
Insider Transaction Report
Form 4
Feder Julie B
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-10-30$6.82/sh−3,385$23,091→ 69,600 total
Footnotes (2)
- [F1]The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.80 to $7.1822, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001710237
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 6:24 PM ET
- Size
- 5.3 KB